Big ideas deserve bold learning. Book a meeting and let’s get started.

Author: Avi Sheshachalam

  • Promise and Challenges of Cell Therapy

    Promise and Challenges of Cell Therapy
    , , ,

    Cell therapy isn’t as new as many believe. The concept of using cells as a therapeutic tool has been around for centuries. Blood transfusions, for instance, have been saving lives for centuries, and xenotransplantation, like using pig heart valves in humans, has been performed since the 1960s. These are early forms of ‘cell-based’ therapies that… Read more

  • Biotech’s 2024 Insane Megarounds: Rise of Giants or a Bubble in the Making?

    Biotech’s 2024 Insane Megarounds: Rise of Giants or a Bubble in the Making?
    , ,

    There’s one thing biotech VC funding loves, it’s cycles—hype, bust, and everything in between. 2024, though? This year is bringing us something different, something big—Megarounds. And when I say big, I mean monumental. But before we get into the numbers, let’s talk about the journey that brought us here. Remember when the synthetic biology space… Read more

  • Drug Development Hacks for New Biotech Trailblazers

    Drug Development Hacks for New Biotech Trailblazers

    For more details, browse through the full blog post! Blog 2 – Phase appropriate material production by Avi You could choose anywhere between 3 to 10 million USD manufacturing strategies for your Phase I/II material. Keep in mind that faster and cheaper is not always better, but not by definition worse. Youri van Nuland /… Read more

  • Biotech VC world

    Biotech VC world
    ,

    Navigating biotech funding Shifting Landscape of Biotech Venture Capital: Challenges, Trends, and the Road Ahead. Key takeaways Venture Capital Expectations Investors want to see not just potential but a solid foundation of evidence that the technology is viable and that there is a market for it (bigger is better) Who you know matters In a… Read more